A tighter archive for life-science signals.
Search once, then narrow by source or topic.
New TNFR1 antagonists disclosed in Dana-Farber Cancer Institute patent
New TNFR1 antagonists disclosed in Dana-Farber Cancer Institute patent
Chinese scientists discover new GTPase KRAS mutant inhibitors
Chinese scientists discover new GTPase KRAS mutant inhibitors
Holiday notice
Holiday notice
Appeals court says no to cap on indirect costs in NIH grants
Appeals court says no to cap on indirect costs in NIH grants
Drugs to Watch 2026: 11 therapies that could transform patient care
Drugs to Watch 2026: 11 therapies that could transform patient care
New year sees Abbvie, Zelgen in $1.1B T-cell engager deal
New year sees Abbvie, Zelgen in $1.1B T-cell engager deal
AI drug discovery brings $2B+ Sanofi deal to 1-year-old Earendil
AI drug discovery brings $2B+ Sanofi deal to 1-year-old Earendil
Insilico inks $888M drug discovery partnership with Servier
Insilico inks $888M drug discovery partnership with Servier
Scinopharm wins US FDA approval of multiple sclerosis drug
Scinopharm wins US FDA approval of multiple sclerosis drug
Financings for Jan. 6, 2026
Financings for Jan. 6, 2026
Appointments and advancements for Jan. 6, 2026
Appointments and advancements for Jan. 6, 2026
Other news to note for Jan. 6, 2026
Other news to note for Jan. 6, 2026
Regulatory actions for Jan. 6, 2026
Regulatory actions for Jan. 6, 2026
Med-tech gainers and losers for Dec. 29, 2025-Jan. 2, 2026
Med-tech gainers and losers for Dec. 29, 2025-Jan. 2, 2026
US vaccine schedule slashed to international standards
US vaccine schedule slashed to international standards
Appointments and advancements for Jan. 5, 2026
Appointments and advancements for Jan. 5, 2026
Financings for Jan. 5, 2026
Financings for Jan. 5, 2026
Other news to note for Jan. 5, 2026
Other news to note for Jan. 5, 2026
Brand directory, kept in view
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page